Found: 7
Select item for more details and to access through your institution.
Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 20, p. 2498, doi. 10.3390/cells12202498
- By:
- Publication type:
- Article
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6037, doi. 10.3390/ijms23116037
- By:
- Publication type:
- Article
Infections with Human Rhinovirus Induce the Formation of Distinct Functional Membrane Domains.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2007, v. 20, n. 1-4, p. 241, doi. 10.1159/000104170
- By:
- Publication type:
- Article
Rhinoviral Infections Activate p38MAP-Kinases Via Membrane Rafts and RhoA.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2006, v. 17, n. 3/4, p. 159, doi. 10.1159/000092077
- By:
- Publication type:
- Article
The Roles of AGTRAP, ALKBH3, DIVERSIN, NEDD8 and RRM1 in Glioblastoma Pathophysiology and Prognosis.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 926, doi. 10.3390/biomedicines12040926
- By:
- Publication type:
- Article
Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2624, doi. 10.3390/cancers13112624
- By:
- Publication type:
- Article
Ceramide metabolism determines glioma cell resistance to chemotherapy.
- Published in:
- Journal of Cellular Physiology, 2009, v. 221, n. 3, p. 688, doi. 10.1002/jcp.21907
- By:
- Publication type:
- Article